SCHEMBL5709284

SCHEMBL5709284

COC(=O)[C@H](C)[C@@H](C)O.[LiH]

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.44
CA14 Q9ULX7 3/20 0.41
CA12 O43570 2/20 0.38
ALDH1A1 P00352 2/20 0.33
KMT2A Q03164 2/20 0.33
ABCB1 P08183 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
TP53 P04637 1/20 0.32
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8500718 0.97
SCHEMBL25600194 0.97
SCHEMBL6907462 0.97
SCHEMBL29616471 0.97
SCHEMBL7123594 0.97
SCHEMBL8498697 0.97
SCHEMBL29309526 0.97
SCHEMBL784551 0.82 SMN1; SMN2 (0.52) SMN1; SMN2CA14CA12ALDH1A1KMT2A
SCHEMBL13946795 0.82 SMN1; SMN2 (0.52) SMN1; SMN2CA14CA12ALDH1A1KMT2A
SCHEMBL28661109 0.81 SMN1; SMN2 (0.42) SMN1; SMN2CA14CA12ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1727533-A1 USE OF CYSTEINYL LEUKOTRIENE 2 RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2006-12-06 EP disclosed
WO-2005082346-A1 USE OF CYSTEINYL LEUKOTRIENE 2 RECEPTOR ANTAGONISTS MERCK & CO, INC. (US) 2005-09-09 WO disclosed